Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis [2]

Clinical Nephrology

Volumn 58, Issue 2, 2002, Pages 168-170

  Okada, T ^a   Nakao, T ^a   Matsumoto, H ^a   Nagaoka, Y ^a   Iwasawa, H ^a   Nanri, K ^a   Yamazaki, T ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VALACICLOVIR; VIRUS ANTIBODY; ACICLOVIR; ANTIVIRUS AGENT; DRUG DERIVATIVE; VALINE;

AGED; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPLEMENT FIXATION TEST; CONSCIOUSNESS DISORDER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG WITHDRAWAL; DYSARTHRIA; HEMODIALYSIS; HERPES ZOSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; LETTER; MALE; MYOCLONUS; NEUROLOGIC DISEASE; RASH; VARICELLA ZOSTER VIRUS; CHRONIC KIDNEY FAILURE; TOXICITY AND INTOXICATION;

ACYCLOVIR; AGED; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NEUROTOXICITY SYNDROMES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; VALINE;

EID: 0036023022     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58168     Document Type: Letter

References (14)

1. Acyclovir neurotoxicity following oral therapy: Prevention and treatment in patients on hemodialysis
2. Neuropsychiatric toxicity in a patient undergoing hemodialysis and receiving treatment with oral acyclovir
3. Neurotoxicity of acyclovir in patients with end-stage renal disease treated with continuous ambulatory peritoneal dialysis
4. Acyclovir-associated encephalopathy, lack of relationship between acyclovir levels and symptoms
5. More about acyclovir neurotoxicity in patients on haemodialysis
6. Acyclovir-induced neurotoxicity: Concentration-side effect relationship in acyclovir overdose
7. Neurotoxicity of valacyclovir in peritoneal dialysis: A pharmacokinetic study
8. Neurotoxicity associated with acyclovir in end-stage renal failure
9. Neurotoxicity caused by valacyclovir in a patient on hemodialysis
10. Neurotoxicity associated with oral acyclovir in patients undergoing dialysis
11. Valacyclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpes virus infections
12. Neurologic toxicity caused by zelitrex (valacyclovir) in 3 patients with renal failure. Is overdose associated with improvement of product bioavailability improvement?
13. Distinguishing acyclovir neurotoxicity from encephalomyelitis
14. Clinical pharmacokinetics of oral acyclovir in patients on continuous ambulatory peritoneal dialysis